This mechanism is analogous to other metabolic-immune interactions, such as those mediated by IGF2BP1 and PRMT3 (31), highlighting the essential role of metabolic reprogramming in immune escape during the progression of HCC. The gene discussed is PRMT3; the disease is hepatocellular carcinoma.